PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Cancer Res. Author manuscript; available in PMC 2010 October 1.
Published in final edited form as:
PMCID: PMC2913896
NIHMSID: NIHMS140259

Role of SV40 Integration Site at Chromosomal Interval 1q21.1 in Immortalized CRL2504 Cells

Abstract

We have applied a functional gene transfer strategy to demonstrate the importance of viral integration site in cellular immortalization. The large tumor antigen of SV40 is capable of extending the cellular life span by sequestering tumor suppressor proteins pRB and p53 in virus-transformed human cells. Although SV40-LT is essential, it is not sufficient for cellular immortalization, suggesting that additional alterations in cellular genes are required to attain infinite proliferation. We demonstrate here that the disruption of human chromosomal interval at 1q21.1, by SV40 integration, can be an essential step for cellular immortalization. The transfer of a 150Kb bacterial artificial chromosome (BAC) clone, RP364B14, corresponding to viral integration site in CRL2504 cells, reverted their immortal phenotype. Interestingly, the BAC transfer clones of CRL-2504 cells displayed characteristics of either senescence as shown by β-galactosidase activity or apoptosis as revealed by positive staining with M30 cytoDeath antibody. The SV40 integration at 1q21.1, in the vicinity of epidermal differentiation complex genes, resulted in the down-regulation of the filaggrin (FLG) gene that is part of the epidermal differentiation complex. FLG gene expression was restored to its normal levels in BAC transfer senescent and apoptotic clones. Our results suggest that the disruption of native genomic sequence by SV40 may alter expression of genes involved in senescence and apoptosis by modulating chromatin structure. These studies imply that identification of genes located in the vicinity of viral integration sites in human cancers may be helpful in developing new diagnostic and therapeutic strategies.

Keywords: SV40 Integration Site, Senescence, Apoptosis, Filaggrin, Chromatin Structure

INTRODUCTION

The mechanisms of neoplastic transformation have been addressed by using human cells immortalized with DNA tumor viruses or viral sequences, such as SV40 large T antigen (SV40-LT), HPV16-E6 and E7 and adenovirus E1A and E1B (1). A two stage model consisting of M1 (mortality stage 1) and M2 (mortality stage 2) has been proposed for SV40-LT induced immortalization of human cells (2). The cells challenged with SV40 large T antigen bypass M1 stage and continue to multiply until they reach M2 stage (2). Subsequently, the entire cell population enters a state of crisis that is characterized by massive cell death through apoptosis or necrosis (3). However, a rare variant cell (1 in 107–8) survives the crisis state and continues to multiply indefinitely (2). These studies suggest that M1 and M2 are regulated through separate genetic controls, and immortalized cells have either inactivated or bypassed regulatory pathways involved in both M1 and M2 stages.

The presence of SV40 has been reported in some human tumors such as mesothelioma, osteosarcoma, ependymomas (47), bronchopulmonary carcinoma and non-malignant pulmonary disease (8). Despite these observations, the role of SV40 in human cancers remains controversial. On the other hand, HPV has been detected in greater than 99% of cervical cancer cases (9). Although the above observations suggest viral etiology of these cancers, the contribution of disrupted host genes due to integration of viral genome has not been addressed.

It has been demonstrated that SV40-LT releases the host cell from the G1 checkpoint (M1 stage) and extends its life span by sequestering pRB and p53 family of tumor suppressor proteins (1012). In order for cell to attain indefinite growth potential, however, additional mutations in cellular genes are essential to bypass M2 stage (2). Although SV40 is known to integrate randomly at multiple sites in the host genome, the immortalized cells often show its integration at a unique site. We propose that the disruption of a specific genomic site due to the viral integration may contribute to malignant transformation of human cells. Furthermore, the integration of SV40 into a specific genomic site may promote genomic instability and likely confer growth advantage.

We have applied a functional approach to restore senescence in SV40 immortalized cells and investigated the role of the integration site in cellular immortalization. We have characterized the genomic region in the vicinity of the site interrupted by SV40 integration. The introduction of a genomic clone, corresponding to the genomic site disrupted by SV40 at 1q21.1, restores senescence or apoptosis in CRL2504, an immortalized cell line.

MATERIALS AND METHODS

Cell lines and growth conditions

A single cell subclone of a human bronchial epithelial cell line, immortalized with a cloned Ori SV40 (13), was used in these studies. CRL-2504 cells contain a single integrated copy of SV40 genome and do not contain any free virus (J. Liu and R. S. Athwal, unpublished observations). The cell lines used for comparison included normal human diploid fibroblasts (HDFs), GMO3468A (Genetic Mutant Cell repository, Camden, NJ) and FS-2 (generated in the lab). The cell lines were routinely cultured at 37°C in a 7.5% CO2 atmosphere in DF/12 media supplemented with 10% fetal bovine serum (FBS) containing 1% penicillin and streptomycin. The gene transfer clones carrying neo marker were isolated and maintained in the medium containing G418 (400 μg/ml)

Isolation of human DNA flanking SV40 insertion site by inverse PCR

The EcoRI digested CRL-2504 DNA (400 ng) was circularized by overnight incubation at 16°C in an appropriate reaction buffer containing 2 μl of T4 DNA ligase (New England Biolabs, Beverly, MA). The circularized DNA was amplified with the primer pair SV40 F1726/SV40R796 specific to the SV40 sequences flanking the human genomic DNA. The amplification was performed in a 25 μl reaction mixture containing 5 μl of ligation products, 2 mM MgCl2, 200 μM each of dNTPs, 1 μM of each primer and 1 unit of Taq polymerase (Promega, Madison, WI). The reaction conditions included initial denaturation at 96°C for 5 minutes, followed by 35 cycles of 1 min at 94° C, 1 min at 58° C and 2 min at 72° C. The amplified products were fractionated by electrophoresis in a 2% agarose gel, visualized by ethidium bromide staining and purified from the gel for cloning.

Transfer of BAC clone into CRL-2504 cells

The BAC clones BAC RP11-364B14 and 152L6 were retrofitted with MJ0X166 to incorporate neo marker, using a vector exchange procedure (14). Briefly, human DNA inserts from the BAC clones were released by digestion with NotI restriction enzyme (New England Biolab, Beverly, MA) and separated by pulsed- field gel electrophoresis (PFGE). The purified inserts were mixed separately with NotI digested and dephosphorylated retrofitting vector pJMOX166 at a molar ratio of 2:1 or 4:1 and ligated using T4 DNA ligase at 16° C for 16 hours. An aliquot (1 μl) of the ligated products was transformed into competent DH-5α cells and cells were plated on LB agar plates containing chloramphenicol (12.5μg/ml) and kanamycin (30μg/ml). The DNA isolated from the retrofitted clones was digested with NotI, fractionated by PFGE and blotted onto a membrane. The blot was hybridized with DNA probes for the co-localization of human insert and pJMOX166. The presence of neo marker in the retrofitted BAC clones was confirmed by PCR.

The DNA from retrofitted BAC clones 364B14 and 152L6 were transferred into mammalian cells by eletroporation using published procedure (15). Briefly, exponentially growing cells were harvested by trypisnization, washed twice in media without serum and suspended in 0.4 ml of serum free media at a density of 2.5 × 107 cells per ml. The BAC DNA (5 μg) was added to the cell suspension, mixed gently and transferred into a cuvette (BioRad) for electroporation using 350V and 500 μFb that produced a time constant in the range of 10–20 seconds (BioRad’s Gene Pulser Apparatus with Capacitance Extender). The cells were placed on ice for 5 minutes immediately after electroporation and then plated on five tissue culture dishes (100 mm) in complete media. The medium was replaced after 24 hours with selection medium containing G418 (400ug/ml) and refreshed every two days on a regular basis. A control experiment was also performed by transferring empty vector pJMOX166 into cells and the transfected cells were selected as above.

Analysis of BAC transfer clones

The BAC transfer colonies that grew in selection medium were either isolated individually or followed in plates. The growth of individual colonies was monitored and their morphology visualized using a phase contrast microscope and photographed at regular intervals.

i. Staining for senescence associated β-galactosidase (SA β-gal) activity

The cells in culture dishes were washed with PBS and fixed in 2% formaldehyde/0.2% glutaraldehyde at room temperature. The staining solution (1 mg of 5-bromo-4-chloro-3-indolyl β-galactosidase per ml, 40 mM citric acid/sodium phosphate, pH 6.0, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 150 mM NaCl, 2 mM MgCl2) was overlaid on fixed cells and incubated at 37°C for 16h (16). The stained cells were visualized using an inverted phase contrast microscope and photographed.

ii. BrdU incorporation assay for DNA replication

The cells (2000 cells/chamber) in an 8-chamber slide (Nalgene Nunc International., Naperville, IL) were incubated for 24h at 37°C and then BrdU (10 μM) was added to the medium. The incubation with BrdU was carried out for 24 hours and the cells were subsequently fixed for 45 min in a fixative solution (7 volumes ethanol and 3 volumes 50 mM glycine). The fixed cells were hybridized with a 1:600 dilution of mouse anti-BrdU monoclonal antibodies (Molecular probes, Eugene, OR) and signal was detected by staining with a 1:200 dilution of the Alexa Fluor 488 conjugated donkey anti-mouse IgG. The nuclei were stained with DAPI and cells visualized under a fluorescence microscope.

Analysis for Apoptosis

CytoDEATH antidody M30 (Roche Diagnostic Corp., Indianapolis, IN), which recognizes a specific caspase cleavage site within CK18, were used to detect apoptosis (17). The cells were seeded on 8-chamber slides (Nalgene Nunc International, Naperville, IL) and fixed in ice-cold methanol at −20°C for 30 minutes. The fixed cells were treated with 0.25% Triton X-100 (Sigma, Saint Louis, Mo) and then incubated for 2 h with donkey serum (Molecular Probes, Eugene, OR). The slides were overlaid with a solution (100μl) containing M30 antibody and incubated at 4°C overnight. The signal was detected by staining with a 1:200 dilution of donkey anti-mouse IgG linked with Alexa Fluor 488 (Molecular probes, Eugene, OR) and cells photographed using Olympus AHVT3 fluorescence research photomicroscope system.

Sequences of primers

Sequences of various PCR primers used are as the follows

SV40-1726F:5′-ACA GTT TAC AGA TGA CTC TCC-3′
SV40-796R:5′-TTG CAG TAA AGC TGC AAA TCC-3′
SV40-1745F:5′-CCA GAC AAA GAA CAA CTG CC-3′
SV40-477 R:5′-CCG TCA ACA GTA TCT TCC CC-3′
H-F87:5′-GAT CCC AAC TAA AAC ATC ACC-3′
H-R484:5′-AGC CCT TAT TGT TTA AAA GAC C-3′
SV2504-IS-F165:5′-CTT CTG TTA TAT CAT TTG ACC C-3′
SV2504-IS-R453:5′-TAC TGT TTC ATT CCT TGA GCC-3′
Neo-F1289:5′-TCA CGA CGA GAT CCT CGC C- 3′
Neo-R1705:5′-TTG TCA AGA CCG ACC TGT CC-3′
GAPDH-F420:5′-AGA AGG CTG GGG CTC ATT TG – 3′
GAPDH-R1080:5′-TCC ACC ACC CTG TTG CTG TA – 3′

Fluorecent In Situ Hybridization (FISH)

Normal human mononuclear cells from peripheral blood were cultured in the presence of 0.05 μg/ml phytohaemagglutinin (Gibco, Grand Island, NY), treated with 0.05–0.1 μg/ml colcemide (Gibco) for one hour, exposed to standard hypotonic solution (75 mM KCl) and fixed in 3:1 absolute methanol/glacial acetic acid. Fixed cells were transferred to glass slides to prepare metaphase chromosome spreads. The metaphase chromosome spreads were hybridized with a mixture of 1 μg of biotin labeled BAC DNA and 100 μg of human Cot-1 DNA (Clontech Laboratories). The detection of the hybridized BAC DNA, digital image acquisition, processing and direct visualization on G-banded chromosomes were all carried out as described earlier (18).

RESULTS

Cloning of human DNA sequence flanking the SV40 DNA

A restriction map for the integrated p129-SV40 in CRL-2504 was first deduced by Southern blot analysis of the DNA digested with BamHI, BstXI, EcoRI, KpnI, PstI, and PvuII either individually or with a combination of two enzymes. The digestion of CRL2504 DNA with EcoRI generated 2.2kb and 5.1kb fragments that were linked to SV40 DNA. The inverse PCR with primer pair SV40-1726F/796R directed to 2.2 Kb fragment of EcoRI digested CRL-2504 DNA generated a 1200bp amplicon. The origin of this fragment from the SV40-human DNA junction was confirmed by PCR using primer pair SV40-1745F/477R that were internal to the first set of primers. The 1200bp PCR product, designated as SV2504-IS, was cloned into pGEM-T easy vector (Promega, Madison, WI) and sequenced. The database search and BLAST comparison revealed this fragment to contain 552bp of human DNA linked to 648bp of SV40 sequence (Figure 1A). The identity of the rescued DNA was further confirmed by PCR amplification of human DNA with primer pair H-F87/H-R484 designed from the recovered human DNA sequence. These primes amplified an expected 297bp product from the human DNA template (data not shown).

Figure 1
Sequence surrounding SV40 integration site and its chromosomal location. A. The sequence flanking the integration site was isolated by inverse PCR as described in the Methods’ section. The locations of SV40 primers used for amplification are indicated ...

Identification of a BAC clone corresponding to SV40 integration site in CRL-2504 cells

A human PCR ready BAC library (Research Genetics, Huntsville, AL) was screened with primer pair H-F87/H-R484 that led to the identification of a 115kb clone RP11-364B14. This clone, obtained from Research Genetics (Huntsville, AL), was found to represent the human–SV40 junction sequence. The position of the BAC was mapped to chromosome 1 by aligning the 552 bp cloned human DNA sequence against genome database. The location of the BAC at 1q21.1 was further confirmed by FISH to the chromosomes prepared from peripheral blood lymphocytes (Figure 1B).

Functional testing of BAC RP11-364B14 by introduction into CRL 2504 cells

The neo marker containing retrofitted BAC clones RP11-364B14 and 152L6 (14) and empty vector pJMOX166 were transfected into CRL-2504 cells by electroporation. The empty vector pJMOX166 and BAC 152L6, known not to affect the growth of immortal cell lines (RSA Unpublished Results), served as control transfections. The BAC transfer colonies, which grew in G418 medium were isolated individually into 60 mm dishes or followed in the plate. A total of 89 independent colonies were isolated following the transfer of RP11-364B14, and 50 colonies were isolated for each of the control transfections. The presence of the transferred DNA in these clones was ascertained by PCR using neo-specific primer pair F1289/R1705 (data not shown).

BAC transfer colonies and control colonies were classified as senescent, apoptotic or immortal based on their growth characteristics and morphology. Eleven out of 89 CRL-2504/364B14neo colonies (12.4%) displayed characteristic senescent phenotype (Figure 2A), 9 colonies (10.1%) became apoptotic (Figure 2B), and 69 colonies (77.5%) retained the immortal parental cell phenotypes. Our data may be biased in favor of immortal colonies for the reason that some of the senescent colonies may have been eliminated at an early stage prior to being recognized and/or camouflaged by the fast growing immortal colonies.

Figure 2
Morphology of senescent and apoptotic transfer clones. A. Senescent transfer clones of CRL2504/BAC364B14 were grown and photographed after 21 days (panel 1), 28 days (panel 2), 35 days (panel 3) and 42 days (panel 4). B. CRL2504 cells 8 weeks after transfection ...

Analysis of BAC transfer colonies

i) Senescent colonies

Senescent colonies grew at a slow rate and the cells appeared enlarged, flattened and highly vacuolated (Figure 2A). The doubling time of cells was assessed by counting cells at regular intervals, either under a phase contrast microscope or in photomicrographs. These cells displayed an initial doubling time of 30–36h that progressively increased to 4–7 days and terminated in complete growth arrest after a period of 6–8 weeks. These cells were attached to the plates and their senescent phenotype was chemically detectable by the SA-β gal activity (Figure 3B).

Figure 3
Visualization of cells after BrdU incorporation and senescence associated β-galactosidase (SA-βgal) assay. A. Native CRL2504 cells (panel 1) and BAC364B14 transfer clone #10 (panel 3) were visualized with anti-BrdU antibody after growing ...

The lack of DNA replication, a hallmark of senescent cells, was assessed by BrdU incorporation in specific BAC transfer colonies and cells from control transfer experiments. The cells were subsequently stained with 4′,6-Diamidino-2-phenylindole (DAPI) to visualize nuclei and determine the relative abundance of BrdU positive cells. A small proportion (1–7%) of cells in the senescent colonies were positive for DNA replication, while more than 90% of cells in control cultures were undergoing DNA replication (Figure 3A).

ii) Apoptotic colonies

The proliferation rate for nine BAC transfer colonies was similar to the parental CRL-2504 cells during the initial period lasting for about 21–30 days (data not shown). However, after about 4 weeks, these cells became rounded, detached from the plate surface and entered a phase of apoptosis (Figure 2B). The apoptotic cells were collected from each colony and examined after staining with M30 CytoDEATH antidody (Roche Diagnostic Corporation, Indianapolis, IN). All nine colonies stained positive for M-30 CytoDEATH antibody (Figure 4), while colonies recovered from control experiments did not show any staining. These data demonstrate that BAC 364B11 induces apoptosis in CRL-2504 cells.

Figure 4
Staining of apoptotic cells with cytoDEATH M30 antibody. Native CRL2504 cells (A), vector transfer clone (panel B), BAC364B14 transfer clone (panel C) and floating cells from the dish containing BAC364B14 transfer clone (panel D) were stained with cytoDEATH ...

iii) Immortal colonies

The immortal neo positive colonies recovered from 364B14neo transfer and control transfer experiments consisted of compact cells that were identical to untransfected CRL-2504. The immortality of these colonies was confirmed by their ability to proliferate in culture beyond 15 passages. These cells did not show SA-β gal activity and were positive for BrdU staining (data not shown). Although the structure of integrated BAC in these cells was not characterized, we speculate that the BAC became rearranged or had lost DNA sequence during transfer or after integration into the host cell genome.

Expression of profilaggrin (FLG) transcript is altered in CRL2504 cells

The chromosome interval at 1q21.1 encodes the epidermal differentiation complex (EDC) that consists of S100A11, thrichohyalin (THH), and profilaggrin (FLG) genes. All three genes are expressed in terminally differentiated epithelial cells (19). A semi-quantitative RT-PCR revealed that FLG transcript was expressed at very low levels in CRL2504 cells, while its expression was restored to normal levels in the BAC transfer senescent cells (Figure 5). These results suggest that FLG down-regulation may be associated with cellular immortalization.

Figure 5
Semi-quantitaive evaluation of filaggrin (FLG) transcript by RT-PCR. A. RT-PCR was performed with FLG specific primers and GAPDH primers on total RNA isolated from CRL2504 parent (lane 1), CRL2504/pJMOX166 vector control (lane 2), CRL-2504/152L16 (lane ...

Our data clearly demonstrate that the introduction of genomic DNA, corresponding to the viral integration site in SV40 immortalized cells, induces senescence and/or apoptosis in the parent cells. The results are consistent with the notion that the site of viral insertion in the host genome is important for immortalization of human cells. Our observations may help explain the virus-induced carcinogenesis in cancers such as cervical cancer.

DISCUSSION

The transfer of a native 150 kb human BAC clone that spans the SV40 integration site at 1q21.1 in CRL-2504 cells, restores cellular senescence and/or apoptosis. The newly acquired senescent phenotype in the transfer clones is likely due to the complementation of the loci disrupted by SV40 integration in CRL-2504 cells. These findings support the hypothesis that integration of SV40 in the host genome may be a prerequisite for the acquisition and maintenance of the immortal phenotype in human cells. Furthermore, immortalization may likely involve altered expression of the senescence and/or apoptosis genes mapping proximal to the SV40 integration site.

Although SV40 T antigen-mediated inactivation of pRb and p53 pathways extends the life span of cells, these changes by themselves are not sufficient to promote infinite cell proliferation. To acquire infinite growth potential, the cells require additional mutations or altered expression of host genes. The disruption of the host genome structure due to the integration of SV40 sequences may contribute toward immortalization of host cells. However, the implication of SV40 integration site for immortalization is complicated by the presence of episomal virus that can self-replicate and cause multiple random integrations in the host genome (RSA unpublished results, 20, 21, 23). The CRL2504 cells used in our studies, carry a single integrated copy of the viral genome and contain no episomal viral particles (data not shown), thus making it feasible to address the role of a specific integration site in immortalization. We have clearly demonstrated that functional reconstitution of the disrupted site is sufficient to restore normal growth pattern, senescence and/or apoptosis in CRL2504 cells.

FRA1F, a common aphidicolin-inducible fragile site, maps near the SV40 integration site in CRL2504 cells. The disruption of fragile sites is known to mediate aberrant gene expression as evidenced by the amplification of MET oncogene and deletions of FHIT and WWOX tumor suppressor genes (24). Similarly, recombinant adeno-associated virus integrates at fragile sites harboring oncogene or tumor suppressor genes (25), and recombinant murine leukemia virus has been found within FRA11E fragile site near the LMO2 oncogene (26). The altered expression of specific genes is illustrated by integration of HBV into cyclin A gene (27), MLV into transcription start sites (28), HIV-1 into transcriptionaly active genes (29), TBLV near c-myc locus (30), and ecotropic murine leukemia virus into STAT5A gene (31).

The SV40 integration site on chromosomal interval 1q21.1 in CRL-2504 cells maps within the epidermal differentiation complex (19) that comprises S100 proteins (32), cell envelop precursor proteins, and the fused-type proteins such as profilaggrin (FLG) and trichohyalin-like 1 (THHL1) (33). These genes are clustered within a 2.0 Mb of genomic DNA interval at 1q21.1. In particular, S100A11 and S100A10 genes, members of a large family of EF-hand calcium-binding proteins (34), are located in the close vicinity of BAC364B14. The altered expression of specific members of S100 family has been reported in colorectal cancers (35), breast cancer-derived metastatic axillary lymph nodes (36) and skin cancers (32). Interestingly, S100A11 is one of the 376 genes specifically up-regulated during senescence in human fibroblasts (37). FLG, a major protein component of the keratohyalin granules of mammalian epidermis, has been implicated in several keratinizing disorders (3840). We have shown reduced expression of FLG transcript in CRL-2504 cells and restoration of the transcript to its normal levels in senescent BAC transfer clones. Our results conform to altered expression of EDC genes observed in cancers and other disorders and point to possible involvement of FLG protein in epithelial cell senescence. It is noteworthy that we have been unable to demonstrate the disruption of any specific gene through SV40 integration. The reduced expression of FLG transcript may be attributed to inactivation of one allele by alterations in a regulatory region upstream of the gene. Alternatively, disruption of the higher order chromatin structure and epigenetic programming (41), mediated by SV40 insertion may also contribute to the decreased gene expression. Such decrease in transcript levels may lead to haploinsufficiency of the gene product as shown for tumor suppressor genes Pten and Smad4/Dpc4 (42, 43).

The senescent and apoptotic phenotypes observed in BAC transfer clones of CRL-2504 cells warrant a comparison of their biological relevance. The evolution of cellular senescence is considered to be a fail-safe mechanism against the risk for neoplastic transformation in normal cells. For this reason, the underlying significance of cellular senescence is quite similar to apoptosis. While apoptosis eliminates potential cancer cells, cellular senescence irreversibly arrests their growth (44). The other similarities in underlying mechanisms may be drawn from the fact that the induction of both these phenotypes can be mediated by p53 and pRB pathways and a common set of stimuli, such as dysfunctional telomeres, DNA damage, disrupted chromatin structures, altered expression of certain oncogenes and supraphysiologic mitogenic signals (44).

In conclusion, we have demonstrated the importance of SV40 integration site in cell immortalization and characterized the ability of the native genomic sequence containing BAC clone to restore the senescent or apoptotic phenotype. Our results are consistent with the proposed ability of the integrated viral genome to modulate the chromatin structure and expression of senescence and apoptosis genes mapping to the chromosomal interval 1q21.1. These observations set the foundation for investigating the integration sites for other oncogenic viruses such as HPV and the role of disrupted genes in the development of human cancers.

Acknowledgments

This work was supported in part by the grants from National Institute of Health (CA74983), US Army Breast Cancer Research Program (DAMD17-99-1-9393 and DAMD17-02-1-0574) and Susan G. Komen Breast Cancer Foundation (BCTR9830 and BCTR1092).

References

1. Ozer HL. SV40-mediated immortalization. Prog Mol Subcell Biol. 2000;24:121–53. [PubMed]
2. Wright WE, Pereira-Smith OM, Shay JW. Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol. 1989;9:3088–92. [PMC free article] [PubMed]
3. Shay JW, Pereira-Smith OM, Wright WE. A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res. 1991;196:33–9. [PubMed]
4. Carbone M, Rizzo P, Procopio A, et al. SV40-like sequences in human bone tumors. Oncogene. 1996;13:527–35. [PubMed]
5. Carbone M, Rizzo P, Grimley PM, et al. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med. 1997;3:908–12. [PubMed]
6. Carbone M, Rizzo P, Pass HI. Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene. 1997;15:1877–88. [PubMed]
7. Testa JR, Carbone M, Hirvonen A, et al. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. Cancer Res. 1998;58:4505–9. [PubMed]
8. Galateau-Salle F, Bidet P, Iwatsubo Y, Gennetay E, et al. SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma, and non-malignant pulmonary diseases. J Path. 1998;184:252–7. [PubMed]
9. Dunne EF, Datta SD, Markowitz L. A review of prophylactic human papillomavirus vaccines: Recommendations and monitoring in the US. Cancer. 2008;113:2995–3003. [PubMed]
10. Hunter T. Signal transduction. Cytokine connections. Nature. 1993;366:114–6. [PubMed]
11. Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol. 1996;16:859–67. [PMC free article] [PubMed]
12. Zindy F, Quelle DE, Roussel MF, Sherr CJ. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene. 1997;15:203–11. [PubMed]
13. Schiller JH, Bittner G, Oberley TD, Kao C, Harris C, Meisner LF. Establishment and characterization of a SV40 T-antigen immortalized human bronchial epithelial cell line. In Vitro Cell Dev Biol. 1992;28A:461–4. [PubMed]
14. Mejia JE, Monaco AP. Retrofitting vectors for Escherichia coli-based artificial chromosomes (PACs and BACs) with markers for transfection studies. Genome Res. 1997;7:179–86. [PubMed]
15. Hejna JA, Johnstone PL, Kohler SL, Bruun DA, Reifsteck CA, Olson SB, et al. Functional complementation by electroporation of human BACs into mammalian fibroblast cells. Nucleic Acids Res. 1998;26:1124–5. [PMC free article] [PubMed]
16. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 1995;92:9363–7. [PubMed]
17. Leers MP, Kolgen W, Bjorklund V, Bergman T, Tribbick G, Persson B, et al. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol. 1999;187:567–72. [PubMed]
18. Zimonjic DB, Rezanka L, Popescu NC. Refined localization of the erbB-3 proto-oncogene by direct visualization of FISH Signals on LUT-inverted and contrast-enhanced digital images of DAPI-banded chromosomes. Cancer Genet Cytogenet. 1995;80:100–2. [PubMed]
19. Mischke D, Korge BP, Marenholz I, Volz A, Ziegler A. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex (“epidermal differentiation complex”) on human chromosome 1q21. J Invest Dermatol. 1996;106:989–92. [PubMed]
20. Huang KC, Yamasaki EF, Snapka RM. Maintenance of episomal SV40 genomes in GM637 human fibroblasts. Virology. 1999;262:457–69. [PubMed]
21. Romani M, Baldini A, Volpi EV, Casciano I, Nobile C, Muresu R, et al. Concurrent mapping of an adenovirus 5/SV40 integration site and the U1 snRNA cluster (RNU1) within 400 kb of the chromosome region 1p36.1. Cytogenet Cell Genet. 1994;67:37–40. [PubMed]
22. Lebeau J, Gerbault-Seureau M, Lemieux N, Apiou F, Calvo F, Berthon P, et al. Loss of chromosome 3p arm differentiating tumorigenic from non-tumorigenic cells derived from the same SV40-transformed human mammary epithelial cells. Int J Cancer. 1995;60:244–8. [PubMed]
23. Lu YJ, Dong XY, Guo SP, Ke Y, Cheng SJ. Integration of SV40 at 12q23 in SV40-immortalized human bronchial epithelial cells. Carcinogenesis. 1996;17:2089–91. [PubMed]
24. Popescu NC. Genetic alterations in cancer as a result of breakage at fragile sites. Cancer Lett. 2003;192:1–17. [PubMed]
25. Rivadeneira ED, Popescu NC, Zimonjic DB, Cheng GS, et al. Sites of recombinant adeno-associated virus integration. Int J Oncol. 1998;12:805–10. [PubMed]
26. Bester AC, Schwartz M, Schmidt M, et al. Fragile sites are preferential targets for integrations of MLV vectors in gene therapy. Gene Ther. 2006;13:1057–9. [PubMed]
27. Wang J, Chenivesse X, Henglein B, Brechot C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature. 1990;343:555–7. [PubMed]
28. Wu X, Li Y, Crise B, Burgess SM. Transcription start regions in the human genome are favored targets for MLV integration. Science. 2003;300:1749–51. [PubMed]
29. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell. 2002;110:521–9. [PubMed]
30. Broussard DR, Mertz JA, Lozano M, Dudley JP. Selection for c-myc integration sites in polyclonal T-cell lymphomas. J Virol. 2002;76:2087–99. [PMC free article] [PubMed]
31. Tsuruyama T, Nakamura T, Jin G, Ozeki M, Yamada Y, Hiai H. Constitutive activation of Stat5a by retrovirus integration in early pre-B lymphomas of SL/Kh strain mice. Proc Natl Acad Sci USA. 2002;99:8253–8. [PubMed]
32. Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D, Lee K. S100 proteins in the epidermis. J Invest Dermatol. 2004;123:23–33. [PubMed]
33. Huber M, Siegenthaler G, Mirancea N, Marenholz I, Nizetic D, Breitkreutz D, et al. Isolation and characterization of human repetin, a member of the fused gene family of the epidermal differentiation complex. J Invest Dermatol. 2005;124:998–1007. [PubMed]
34. Wicki R, Marenholz I, Mischke D, Schafer BW, Heizmann CW. Characterization of the human S100A12 (calgranulin C, p6, CAAF1, CGRP) gene, a new member of the S100 gene cluster on chromosome 1q21. Cell Calcium. 1996;20:459–64. [PubMed]
35. Tanaka M, Adzuma K, Iwami M, Yoshimoto K, Monden Y, Itakura M. Human calgizzarin; one colorectal cancer-related gene selected by a large scale random cDNA sequencing and northern blot analysis. Cancer Lett. 1995;89: 195–200. [PubMed]
36. Tomasetto C, Regnier C, Moog-Lutz C, Mattei MG, Chenard MP, Lidereau R, et al. Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17. Genomics. 1995;28:367–76. [PubMed]
37. Zhang Y, Song S, Fong CC, Tsang CH, Yang Z, Yang M. cDNA microarray analysis of gene expression profiles in human fibroblast cells irradiated with red light. J Invest Dermatol. 2003;120:849–57. [PubMed]
38. Baden HP, Roth SI, Goldsmith LA, et al. Keratohyalin protein in disorders of keratinization. J Invest Dermatol. 1974;62:411–4. [PubMed]
39. Holbrook KA, Dale BA, Brown KS. Abnormal epidermal keratinization in the repeated epilation mutant mouse. J Cell Biol. 1982;92:387–97. [PMC free article] [PubMed]
40. Sybert VP, Dale BA, Holbrook KA. Ichthyosis vulgaris: identification of a defect in synthesis of filaggrin correlated with an absence of keratohyaline granules. J Invest Dermatol. 1985;84:191–4. [PubMed]
41. Spofford JB. Single-locus modification of position-effect variegation in Drosophila melanogaster. I. White variegation. Genetics. 1967;57:751–66. [PubMed]
42. Kwabi-Addo B, Giri D, Schmidt K, Podsypanina K, Parsons R, Greenberg N, Ittmann M. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc Natl Acad Sci U S A. 2001;98:11563–8. [PubMed]
43. Izeradjene K, Combs C, Best M, Gopinathan A, Wagner A, Grady WM, Deng CX, Hruban RH, Adsay NV, Tuveson DA, Hingorani SR. Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell. 2007;11:229–43. [PubMed]
44. Campisi J. Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes. Exp Gerontol. 2003;38:5–11. [PubMed]